LU 103793

Known as: LU-103793, LU103793 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1995-2007
012319952007

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
The marine ecosystem that has contributed to the discovery of cytarabine and its fluorinated derivative gemcitabine is now… (More)
Is this relevant?
2003
2003
LU 103793 is a synthetic analogue of Dolastatin 15 that inhibits tubulin polymerisation. The aim of this study was to evaluate… (More)
Is this relevant?
2003
2003
A phase II study of the dolastatin 15 analog LU 103793 was conducted by the North Central Cancer Treatment Group in patients with… (More)
Is this relevant?
2001
2001
LU103793, a synthetic analogue of dolastatin 15, showed interesting pre-clinical activity in melanoma xenografts. In this phase… (More)
Is this relevant?
1999
1999
The linear peptide dolastatin 15 (1), a potent antineoplastic constituent from the shell-less mollusk Dolabella auricularia, has… (More)
Is this relevant?
1998
1998
Cemadotin (LU103793) (NSC D-669356) is a water-soluble synthetic analogue of dolastatin 15 that inhibits cell proliferation in… (More)
Is this relevant?
1998
1998
PURPOSE To determine the maximum-tolerated dose (MTD), dose-limiting toxicities (DLTs), and pharmacokinetic profile of the… (More)
Is this relevant?
1998
1998
PURPOSE To determine the maximum tolerable dose (MTD), principal toxicity, and pharmacologic behaviour of Cemadotin-HCl, a novel… (More)
Is this relevant?
1995
1995
LU103793 (NSC D-669356) is a new synthetic derivative of Dolastatin 15, an antiproliferative compound which was isolated from the… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?